Neurogene (NGNE) Change in Acquisitions & Divestments (2018 - 2025)

Neurogene's Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $72.5 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 360.32% year-over-year to $72.5 million; the TTM value through Dec 2025 reached $284.7 million, up 284.73%, while the annual FY2025 figure was $284.7 million, 284.73% up from the prior year.
  • Change in Acquisitions & Divestments reached $72.5 million in Q4 2025 per NGNE's latest filing, down from $99.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $99.5 million in Q3 2025 to a low of $5.0 million in Q4 2023.
  • Average Change in Acquisitions & Divestments over 3 years is $40.4 million, with a median of $30.0 million recorded in 2024.
  • The largest YoY upside for Change in Acquisitions & Divestments was 1037.14% in 2025 against a maximum downside of 49.0% in 2025.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $5.0 million in 2023, then surged by 215.0% to $15.8 million in 2024, then skyrocketed by 360.32% to $72.5 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Change in Acquisitions & Divestments are $72.5 million (Q4 2025), $99.5 million (Q3 2025), and $68.0 million (Q2 2025).